SolomonI.HamburgMD

PubMed

• 7 citations
  Safety and Efficacy of Ruxolitinib in Patients With Myelofibrosis and Low Platelet Counts (50–100 × 109/L): Final Analysis of an Open-label Phase 2 study
  Moshe Talpaz, Josef T. Prchal, Lawrence B. Afrin, Murat O. Arcasoy, Solomon I. Hamburg
  Clinical Lymphoma, Myeloma & Leukemia. 2021-11-02
• 16 citations
  Evaluation of an alternative ruxolitinib dosing regimen in patients with myelofibrosis: an open-label phase 2 study
  Moshe Talpaz, Susan Erickson-Viitanen, Kevin Hou, Solomon I. Hamburg, Maria R. Baer
  Journal of Hematology & Oncology. 2018-08-07
• 43 citations
  Phase 1 dose-escalation study of IV ixazomib, an investigational proteasome inhibitor, in patients with relapsed/refractory lymphoma.
  Sarit Assouline, Julie E. Chang, Bruce D. Cheson, Robert M. Rifkin, Solomon I. Hamburg
  Blood Cancer Journal. 2014-10-17

Journal Articles

• Interim analysis of safety and efficacy of ruxolitinib in patient with myelofibrosis and low platelet counts  
  Talpaz, M, Paquette, R, Afrin, L, Hamburg, S.I., et. al, J Hematology and Oncology, 1/1/2013
• Heart transplantation using bivalirudin as anticoagulant  
  Simsir SA, Schwarz ER, Czer LS, Hamburg SI, Interact Cardiovasc Thorac Surg, 1/1/2010
• Laparoscopic splenectomy for hairy cell leukemia in pregnancy  
  Adeniji BA, Fallas M, Incerpi M, Hamburg S, Datz R, Ogunyemi D, Case Report Med, 1/1/2010
• Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double - blind randomized controlled trial  
  Kuter, D.J., Bussel, J.B., Lyons, R.M., Pullarkat, V., Gernsheimer, T.B., Senecal, F.M., Aldedort, L.M., Geroge, J.N., Kessler, C.M., Sanz, M.A. Liebman, H. A., Slovic..., Lancet, 1/1/2008
• Phase II trial of nolatrexed dihdrochloride [Thymitaq, AG337] in patients with advanced hepatocellular carcinoma  
  Jhawer M, Rosen L, DanceyJ, Hochster H, Hamburg S, Tempero M, Clendeninn N, Mani S, Invest New Drugs, 1/1/2007
• Phase II multicenter study of induction chemotherapy followed by concurrent efaproxiral (RSR13) and thoracic radiotherapy for patients with locally advanced non-small-...  
  Choy H, Nabid A, Stea B, Scott C, Roa W, Kleinberg L, Ayoub J, Smith C, Souhami L, Hamburg S, Spanos W, Kreisman H, Boyd AP, Cagnoni PJ, Curran WJ, J Clin Oncol, 1/1/2005
• Splenic Infarction Associated with Anti-Cardiolipin Antibody: A Report of Two Cases, Cedars-Sinai Medical Center, Los Angeles, CA  
  Carie L. McVay, MD, Yibin Zhang, MD, Albert Ko, MD, Solomon I. Hamburg MD, PhD, Leslie Memsic, MD, Leon Morgenstern, MD, Allan W. Silberman, MD, PhD, Am Surg, 1/1/2004
• Technetium-99m Sestamibi Scanning Reflects Marrow Activity in a B-Thalassemia Patient Treated with an Allogeneic Bone Marrow Transplant  
  Look, R.M., Koh, H.A., Hamburg, S.I., Lim, S.W., Waxman, A.D., Jochelson, M.S., Gupta, P.K., Fuerst, M.P., Kusuanco, D.A., Lawrence, G.N., and Giles, F.J., Hematology, 1/1/1996
• Mononuclear phagocytes: Responders to and producers of interferon  
  Hamburg, S.I., Fleit H.B., Unkeless, J., and Rabinovitch M., Annals of the New York Academy of Science, 1/1/1980
• Relationship between enhanced macrophage phagocytic activity and the induction of interferon by Newcastle disease virus in mice  
  Hamburg, S.I., Cassell, G.H., and Rabinovitch, M., J Immunol, 1/1/1980
• Interferon induced enhancement of Fc mediated phagocytosis  
  Rabinovitch, M., Hamburg, S.I., and Fleit, H.B., J Reticuleondoth Soc, 1/1/1980
• Interferon-induced enhancement of Fc Receptor-mediated macrophage phagocytosis  
  Rabinovitch, M, Hamburg S.I., Fleit, H.B., J Reticuloendothelial Soc, 1/1/1980
• Serum interferon and phagocytic activity of macrophages in recombinant inbred mice inoculated with Newcastle disease virus  
  Manejias, R.E., Hamburg, S.I., and Rabinovitch, M, Cell Immunol, 1/1/1978
• Macrophage activation: Increased ingestion of IgG-coated erythrocytes after administration of interferon inducers to mice  
  Hamburg, S. I., Manejias, R.E., and Rabinovitch, M., J Exp Med, 1/1/1978
• Bonding in divalent transition metal cyanides Crystal structure of dicesium, magnesium hexacyanoferrate (II)  
  Swanson, B.I., Hamburg, S.I., and Ryan, R.R., Inorg Chem, 1/1/1974
• Join now to see all

Books/Book Chapters

• Medical Screening for California Law Enforcement, 1993. 
  Chapter: Chapter V, Hematology 
  Hamburg, S.I.,Liebman, H.and Weitz, E.1993
• Medical Screening for California Law Enforcement, 1993. 
  Chapter: Chapter VI, Oncology. 
  Hamburg, S.I.,Liebman, H.and Weitz, E.1993
• Guide to Dental Problems for Physicians and Surgeons. 
  Chapter: Hemorrhagic Disorders. 
  Hamburg, S.I. and Rosove, M.Editors: S.R. Thaller and W.W. Montgomery.1988
• Mononuclear Phagocytes, Functional Aspects. 
  Chapter: Macrophage activation by interferon or interferon inducers. Chapter 59 
  Page 1515 - 1538Rabinovitch, M. and Hamburg, S.I.Hague, the Netherlands1980
• Join now to see all

Abstracts/Posters

• Abstract LB-289: A phase I dose escalation study of TKM-080301, a RNAi therapeutic directed against PLK1, in patients with advanced solid tumors.
  Ramesh K. Ramanathan, Solomon I. Hamburg, Mitesh J. Borad, Mahesh Seetharam, Madappa N. Kundranda, Peter Lee, Paul Fredlund, Mark Gilbert, Cathy Mast, Sean C. Semple, ..., AACR, 1/15/2013
• Preliminary Safety and Efficacy from a Phase II study of Ruxolitinib in Patients with Primary and Secondary Myelofibrosis with Platelet Counts of 50-100x109/L.
  Moshe Talpaz, Solomon I. Hamburg, Ktarzyna Jamieson, Howard R. Terebelo, Lawrence Afrin, Elliott F. Winton, Michael A. Scola, Roger M. Lyons, Jimmie Huling Harvey Jr.,..., ASCO, 1/1/2012
• Results of a phase 1 dose-escalation study of once-weekly MLN9708, an investigational proteasome inhibitor, in patients with relapsed/refractory lymphoma.
  Sarit E. Assouline, Julie Chang, Bruce D. Cheson, Robert Rifkin, Solomon Hamburg, Ruben Reyes, Ai-Min Hui, Jiang Yu, Neeraj Gupta, Alessandra Di Bacco, Yaping Shou, P..., ASCO, 1/1/2012
• Survival Benefit of Nolatrexed (THYMITAQ) n Advanced Hepatocellular Carcinoma (aHCC)
  Hamburg, S; Miller, W, Garcia-Vargas J; Joseph, L; Gunwale, L.F.; Horan, J., ASCO, 1/1/2003
• Phase II Study of Amifostine for the Treatment of the Myelodysplastic Syndrome.
  Kemp in, S., Spirit, G., Cache, G., Irwin, D., Gee, T., Stephan, D., Blum, R., Hamburg, S.I., Wilson, E., ASCO, 1/1/1998
• High Dose Chemotherapy (CTX) with Autologous Peripheral Stem Cell Transplantation (PSCT) for Advanced Sarcoma.
  Myong, H., Rosen, G., Forscher, C., Hurvitz, C., Hamburg, S.I., Qasabian, L., Pepkowitz, S., Lill, M., Giles, F.J., ASCO, Cedars-Sinai Medical Center, Los Angeles, CA, 1/1/1998
• Chemoembolization and Transplantation
  Colquhoun, S.D., Ghobrial, R.M., Sue, P., Goss, J.A., Aranout, W.S., Parkasi, A., Friedman, M., Gomes, A.S., Rosove, M.H., Hamburg, S.I.,Shackelton, C.S., Busuttil, R.W., American Society of Transplant Surgeons, 1/1/1997
• Technetium-99m, MIBI scanning in multiple myeloma (MM).
  Durie, B.M.G., Waxman, A.D., Jochelson, M., Giles, F.J., Hamburg, S.I. and Avedon, M., ASCO, 1/1/1996
• MGBG therapy of relapsed extra lymphatic HIV-associated non-Hodgkin's lymphoma (HIV NHL).
  Lim, S.W., Look, R.M., Bick, A.B., Hamburg, S.I., Lawrence, G.N., Fuerst, M.P., Kusuanco, D.A., Kessler, C.E. and Giles, F.J., ASCO, 1/1/1995
• Peripheral blood stem cell (PBSC) yields following nitrosourea-containing and nonequivalent engraftment times post-myeloablative therapy.
  Look, R.M., Lim, S.W., Fuerst, M.P., Jacobs, A.G., Pepkowitz, S.H., Goldfinger, D., Klohn, J.L., Decker, R.W., Hamburg, S.I., Moss, T.J., Hurvitz, C.H., Lawrence, G.N...., ASCO, 1/1/1995
• Utility of methoxyiso-butylisonitrile (MIBI) imaging in multiple myeloma (MM) patients undergoing peripheral blood stem cell (PBSC) transplant.
  Look, R.M., Lim, S.W., Waxman, A.D., Jochelson, M.S., Hamburg, S.I., Decker, R.W., Fuerst, M.P., Lawrence, G.N., Kusuanco, D.A., Kessler, C.E. and Giles, F.J., ASCO, 1/1/1995
• Monitoring of chemo-purging of harvested marrow using a clonogenic assay for patients with acute lymphoblastic leukemia.
  Moss, T.J., Hamburg, S.I., Decker, R.W., and Hurvitz, C., Proceedings American Society of Clinical Oncology, 1/1/1993
• Lack of evidence for early autologous bone marrow transplantation in high-risk lymphoma patients.
  Hamburg, S.I., Decker, R.W., Moss, T.J. and Hermits, C., ASH Proceedings, 1/1/1992
• Phase II study of high dose continuous infusion dimethyl triazeno imidazole carboxamide (DTIC) in metastatic leiomyosarcoma (LMS).
  Rosen, G., Chawla, S., Hamburg, S.I., and Lowenbraun, S., ASCO, 1/1/1990
• Join now to see all

Lectures

• Update in Therapy for P. Vera and Myelofibrosis 
  Cedars-Sinai Medical Center, Los Angeles, CA - 1/15/2016
• Myelofibrosis 2014 
  Cedars-Sinai Medical Center, Los Angeles, CA - 1/26/2014
• The Big Spleen: New diagnostic and management considerations. Myeloproliferative disorders. 
  Marina Del Rey, CA - 1/21/2012
• Cholangiocarcinomas, Systemic Therapies 
  Cedars-Sinai Medical Center, Los Angeles, CA - 1/1/2012
• Thrombocytopenia and Thrombopoiesis Megakaryocyte Development and Pathology, Thrombopoietin Regulation. 
  Cedars-Sinai Medical Center, Los Angeles, CA - 1/11/2010
• Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. 
  Massachusetts General Hospital, Boston, MA - 1/1/2008
• Phase II trial of nolatrexeddihydrochloride" [Thymitaq, AG 337| in patients with advanced hepatocellular carcinoma. 
  Montefiore Medical Center, New York, NY - 1/1/2006
• Phase II multicenter study of induction chemotherapy followed by concurrent efaproxiral (RSR13) and thoracic radiotherapy for patients with locally advanced non-small-... 
  Vanderbilt University Medical Center, Nashville, TN - 1/1/2005
• Splenic infarction associated with anti-cardiolipin antibody: a report of two cases. 
  Cedars-Sinai Medical Center, Los Angeles, CA - 1/1/2004
• Hepatoma Update 2003 
  Cedars-Sinai Medical Center, Los Angeles, CA - 1/1/2003
• Cancer and the Workplace 
  Mount San Antonio College, West Covina, CA - 1/1/2002
• Hematological Emergencies 
  Cedars-Sinai Medical Center, Los Angeles, CA - 1/1/2002
• Malignancy and Solid Organ Transplantation 
  Cedars-Sinai Medical Center, Los Angeles, CA - 1/1/2001
• Non-myeloablative transplantation 
  Cedars-Sinai Medical Center, Los Angeles, CA - 1/1/2000
• Matrix Metallo-Proteases and Cancer 
  Cedars-Sinai Medical Center, Los Angeles, CA - 1/1/2000
• Coagulation Disorders 
  Cedars-Sinai Medical Center, Los Angeles, CA - 1/1/1999
• Novel Therapeutic Approaches for Unresectable Malignancies 
  Cedars-Sinai Medical Center, Los Angeles, CA - 1/1/1997
• Transfusion Therapy 
  Cedars-Sinai Medical Center, Los Angeles, CA - 1/1/1995
• Interferon in Chronic Myelogenous Leukemia 
  Detroit, MI - 1/1/1993
• Interferon induced activation of macrophage 
  New York, NY - 1/1/1980
• Join now to see all